Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
By Bhanvi Satija (Reuters) -Bristol Myers Squibb said on Tuesday it would buy RayzeBio for about $4.1 billion to bolster…
By Bhanvi Satija (Reuters) -Bristol Myers Squibb said on Tuesday it would buy RayzeBio for about $4.1 billion to bolster…
By Gary McWilliams HOUSTON (Reuters) – The oil and gas industry went on a $250 billion buying spree in 2023,…
By Steven Scheer JERUSALEM (Reuters) -Israel’s government agreed to give Intel a $3.2 billion grant for a new $25 billion…
By Lewis Krauskopf NEW YORK (Reuters) – Wall Street is counting on the so-called Santa Claus Rally to bring record…
By Nichola Groom and Cath Turner LOS ANGELES (Reuters) – The angular, polarizing design of the Cybertruck will help boost…
(Reuters) – OpenAI is in early talks to raise a fresh round of funding at a valuation at or above…
By Lucia Mutikani WASHINGTON (Reuters) – U.S. prices fell in November for the first in more than 3-1/2 years, pushing…
By Katherine Masters NEW YORK (Reuters) – Last-minute shoppers looking for late deals ahead of Christmas may find smaller discounts…
By David Shepardson WASHINGTON (Reuters) -Tesla is recalling just over 120,000 Model S and Model X vehicles in the United…
(Reuters) – Attacks on vessels by Iranian-backed Houthi militants in Yemen have disrupted international commerce on the shortest shipping route…